Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy

INCLUSION: * Previously untreated Hodgkin's disease patients who are scheduled to receive standard ABVD chemo. * Histologically proven diagnosis of Hodgkin's disease of any type. * Bidimensionally measurable disease. * Signed informed consent. * Age \>/= 16 yrs. * Adequate bone marrow reserve (ANC\>1000/uL, Platelet \>100,000/uL. * LVEF\>/=50% by MUGA scan or echocardiogram. * Serum creatinine \<2mg/dL; serum bilirubin\<2mg/dL. EXCLUSION: * HIV positive. * Pregnant women and those of child bearing age who are not using adequate contraception. * Prior chemotherapy. * Severe pulmonary disease including COPD and asthma. * History of prior sensitivity to E.coli derived products.